dendritic cell vaccine with mrna from tumor stem cells
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00846456)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dendritic cell vaccine with mrna from tumor stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00846456 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2009 | Osaka University, University of Copenhagen, University of Oslo |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Osaka University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Oslo | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1